FDA

The FDA now allows LabCorp's platform to test patients with no COVID-19 symptoms, or to run samples from up to five patients at a time.

The Patient Controller app works with Abbott's Infinity DBS System, Proclaim XR SCS System and Proclaim DRG Neurostimulation System.

The information is stored and sent to hospital systems and the Vitls app, so healthcare providers can monitor the vital signs of their patients in real time, no matter where they are. 

Mental health problems have been a rising issue globally over the past decade due to an ever more demanding society, in addition to the exponential increase in the use of social media, as reported by the American Psychological Association. Digital health connector, Aline Noizet, takes a closer look at some of the emerging tools available to those suffering with increased mental health challenges during COVID-19.

The device monitors vitals from up to four feet away, and is designed for use in healthcare settings or at home.

Also: TapestryHealth purchases its telehealth tech vendor; Tech professionals eyeing healthcare and pharma jobs with new interest after COVID-19.

The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.

Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.

The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.

The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.